Proteins and Peptides
1 April 2020
Mimetogen Pharmaceuticals Completes Enrollment of MIM-728 Phase 3 Trial for Tavilermide for Dry Eye Disease26 March 2020
Medicenna’s IL-2 Superkine, MDNA19, Demonstrates Best-in-Class Features in a Non-Human Primate Study22 March 2020
Zealand Pharma regains worldwide rights to Amylin analog program from Boehringer Ingelheim11 March 2020
Airway Therapeutics Announces Filing with NIH to Evaluate AT-100 as a Therapy for Novel Coronavirus26 February 2020
APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China21 February 2020
NoNO Inc. Reports Groundbreaking Results from the Phase 3 ESCAPE-NA1 Study of the Peptide, Nerinetide, in Acute Ischemic Stroke20 February 2020
Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL964312 February 2020
Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes11 February 2020
Seurat Therapeutics Announces Novel Mechanisms from Rat Migraine Model of Intranasal Insulin-like Growth Factor-13 February 2020
AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV Coronavirus2 February 2020
CHMP Recommends Approval of Lilly’s New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes31 January 2020
Rani Therapeutics Announces Positive Phase I Study Results of Oral Octreotide using RaniPill™30 January 2020
Theraly Fibrosis Awarded $3.9 Million SBIR Phase II Grant to Support Development of TLY012 for Chronic PancreatitisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports